Video Experimental Relacionado
Updated: Jan 14, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.9K
Las vacunas contra la COVID-19 pueden mejorar la inmunoterapia contra el cáncer
Science (New York, N.Y.)
|October 23, 2025
Resumen
El ARN mensajero (ARNm) en las vacunas contra el cáncer actúa como una sirena, atrayendo a las células inmunes para atacar y eliminar los tumores. Este enfoque innovador aprovecha las defensas naturales del cuerpo para mejorar la destrucción del tumor.
Área de la Ciencia:
- En el campo de la oncología
- Inmunología
- Biotecnología
Sus antecedentes:
- El cáncer sigue siendo la principal causa de mortalidad en todo el mundo.
- Las terapias actuales contra el cáncer tienen limitaciones y efectos secundarios significativos.
- Se necesitan con urgencia nuevas estrategias terapéuticas para mejorar los resultados de los pacientes.
Objetivo del estudio:
- Investigar el potencial de la tecnología de ARN mensajero (ARNm) en la inmunoterapia contra el cáncer.
- Explorar el mecanismo por el cual el ARNm influye en la respuesta inmune contra los tumores.
- Evaluar la eficacia de las estrategias basadas en el ARNm para estimular la inmunidad antitumoral.
Principales métodos:
- Se utilizan secuencias de ARNm diseñadas para codificar antígenos tumorales específicos o proteínas estimulantes del sistema inmunológico.
- Nanopartículas cargadas de ARNm o vectores virales administrados en modelos de cáncer preclínicos.
- Se evaluó la infiltración de células inmunes, la activación y la regresión tumoral mediante citometría de flujo, inmunohistoquímica e imágenes in vivo.
Principales resultados:
- La administración de ARNm atrajo con éxito a los linfocitos T citotóxicos y otras células inmunes al microambiente tumoral.
- Se observó una inhibición significativa del crecimiento tumoral y una regresión en respuesta a los tratamientos basados en ARNm.
- Demostró un efecto "similar a una sirena" donde el ARNm recluta células inmunes para identificar y destruir células cancerosas.
Conclusiones:
- La tecnología de ARNm es muy prometedora como herramienta potente para la inmunoterapia contra el cáncer.
- El "efecto sirena" del ARNm proporciona un nuevo mecanismo para mejorar las respuestas inmunes antitumorales.
- Se requiere una mayor investigación clínica de las vacunas contra el cáncer basadas en ARNm para traducir estos hallazgos en terapias humanas efectivas.
Videos de Conceptos Relacionados
01:30Cancer Vaccines
952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:19Psychoneuroimmunology: Diabetes and Cancer
437
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
437